Skip to main navigation Skip to search Skip to main content

The effect of dorrigocin and migrastatin analogues on angiogenic marker secretions and cellular processes using a human tumour explant model. COST Action Angiokem) Scientific Meeting

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputWorkshops
PublisherAthens, Greece.
Publication statusPublished - 1 Mar 2009

Cite this